Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720039 · ClinicalTrials.gov registry record · NA
Robotic vs. Open NSM for Early Stage Breast Cancer
A NA study of Breast Cancer and Breast Cancer Female, sponsored by Intuitive Surgical.
- Active
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 15
- Study locations
NCT05720039: Active NA study of Breast Cancer and Breast Cancer Female, sponsored by Intuitive Surgical.
NCT05720039 is a NA study of Breast Cancer and Breast Cancer Female that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 204 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 15 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05720039, a NA study of Breast Cancer and Breast Cancer Female, is active but no longer recruiting, sponsored by Intuitive Surgical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 15
- Study locations
Study Summary
This study evaluates the safety and effectiveness of the da Vinci SP Surgical System compared to Open NSM in Nipple Sparing Mastectomy procedures.
Primary Outcome
Conversion is defined as conversion of da Vinci Xi robotic-assisted surgery to open surgery
Conditions Studied
Interventions
- DEVICE Robotic NSM
- PROCEDURE Open NSM
Study Locations (15)
California
- City of Hope - Irvine
- Cedars-Sinai - Los Angeles
Florida
- Mayo Clinic Florida - Jacksonville
Georgia
- Emory University - Atlanta
Illinois
- Endeavor Health - Evanston
Michigan
- Corewell - Detroit
Minnesota
- Mayo Clinic Rochester - Rochester
Missouri
- Washington University, St. Louis - St Louis
New York
- Northwell Health - Lake Success
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2031-03 |
| Phase | NA |
What the registry record for NCT05720039 still lists
NCT05720039 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Robotic NSM is the first listed.
NCT05720039 lists 15 locations in 14 states (California, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT05720039 about?
NCT05720039 is a clinical study titled "Robotic vs. Open NSM for Early Stage Breast Cancer". This study evaluates the safety and effectiveness of the da Vinci SP Surgical System compared to Open NSM in Nipple Sparing Mastectomy procedures.
What is the current status of trial NCT05720039?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2023-05-08. Estimated completion is 2031-03.
What conditions does trial NCT05720039 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female, Breast, Breast Cancer, Early-Onset, Breast Disease.
What interventions are being tested in trial NCT05720039?
The interventions under investigation include: Robotic NSM (DEVICE), Open NSM (PROCEDURE).
Who is sponsoring clinical trial NCT05720039?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05720039 being conducted?
This trial has 15 study locations across California, Florida, Georgia, Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05720039's enrollment target sits among peer trials
204 359th of 1224 higher than 865 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI